Cargando…

The Impact of Host Metabolic Factors on Treatment Outcome in Chronic Hepatitis C

Background. Recent data suggest that chronic hepatitis C has to be considered a metabolic disease further to a viral infection. The aim of this study was to elaborate on the complex interactions between hepatitis C virus, host metabolic factors, and treatment response. Methods. Demographic, virologi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Savvoula, Savvidou, Dimitrios, Chrysagis, George, Papatheodoridis, Spilios, Manolakopoulos, Christos, Triantos, John, Goulis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3346969/ https://www.ncbi.nlm.nih.gov/pubmed/22577373 http://dx.doi.org/10.1155/2012/420156

Ejemplares similares

Monitoring and comorbidities in patients with chronic hepatitis B currently treated with nucleos(t)ide analogs
por: Siakavellas, Spyros, et al.
Publicado: (2021)

Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2017)

Aiming towards hepatitis C virus elimination in Greece
por: Papatheodoridis, George V., et al.
Publicado: (2019)

Epidemiology of hepatitis C in Greece
por: Triantos, Christos, et al.
Publicado: (2016)

Prioritization for interferon-free regimens and potential drug interactions of current direct-acting anti-hepatitis C agents in routine clinical practice
por: Papatheodoridi, Μargarita, et al.
Publicado: (2017)

Elastography for Hepatic Fibrosis Severity in Chronic Hepatitis B or C
por: Papageorgiou, Maria-Vasiliki, et al.
Publicado: (2011)

Clinical and epidemiological characteristics of hepatitis C virus-infected people who inject drugs: a Greek descriptive analysis
por: Kranidioti, Hariklia, et al.
Publicado: (2018)

Role of band ligation for secondary prophylaxis of variceal bleeding
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2018)

Safety and efficacy of daclatasvir in the management of patients with chronic hepatitis C
por: Manolakopoulos, Spilios, et al.
Publicado: (2016)

Predictive performance of newer Asian hepatocellular carcinoma risk scores in treated Caucasians with chronic hepatitis B
por: Papatheodoridis, George V., et al.
Publicado: (2021)

Non-alcoholic fatty liver disease may develop in individuals with normal body mass index
por: Margariti, Ekaterini, et al.
Publicado: (2012)

Outcome after discontinuation of nucleot(s)ide analogues in chronic hepatitis B: relapse rate and associated factors
por: Kranidioti, Hariklia, et al.
Publicado: (2015)

Hepatitis B and C coinfection in a real-life setting: viral interactions and treatment issues
por: Papadopoulos, Nikolaos, et al.
Publicado: (2018)

Serum zonulin levels in patients with liver cirrhosis: Prognostic implications
por: Voulgaris, Theodoros A, et al.
Publicado: (2021)

Boceprevir for chronic HCV genotype 1 infection in treatment-experienced patients with severe fibrosis or cirrhosis: The Greek real-life experience
por: Manolakopoulos, Spilios, et al.
Publicado: (2015)

Pellagra: A Non-Eradicated Old Disease
por: Savvidou, Savvoula
Publicado: (2014)

Efficacy and safety profile of boceprevir- or telaprevir-based triple therapy or dual peginterferon alfa-2a or alfa-2b plus ribavirin therapy in chronic hepatitis C: the real-world PegBase observational study
por: Mangia, Alessandra, et al.
Publicado: (2017)

Reply to Jonkman et al.: Tissue Doppler Imaging of the Diaphragm: A Novel Approach but Too Early for Clinical Implementation?
por: Soilemezi, Eleni, et al.
Publicado: (2020)

Direct-acting antiviral treatment for chronic hepatitis C in people who use drugs in a real-world setting
por: Koustenis, Kanellos Rafail, et al.
Publicado: (2020)

An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study
por: Manolakopoulos, Spilios, et al.
Publicado: (2007)

Liver fibrosis staging with combination of APRI and FIB-4 scoring systems in chronic hepatitis C as an alternative to transient elastography
por: Papadopoulos, Nikolaos, et al.
Publicado: (2019)

Tissue Doppler Imaging of the Diaphragm in Healthy Subjects and Critically Ill Patients
por: Soilemezi, Eleni, et al.
Publicado: (2020)

Sofosbuvir: a novel oral agent for chronic hepatitis C
por: Cholongitas, Evangelos, et al.
Publicado: (2014)

The impact of healthcare professionals’ personality and religious beliefs on the decisions to forego life sustaining treatments: an observational, multicentre, cross-sectional study in Greek intensive care units
por: Ntantana, Asimenia, et al.
Publicado: (2017)

Pretreatment serum interleukin-12 levels in predicting sustained virological response among hepatitis C patients following Pegylated Interferon-α2β plus Ribavirin treatment
por: Perperas, Antony, et al.
Publicado: (2013)

Prognostic significance of vitamin D receptor (VDR) gene polymorphisms in liver cirrhosis
por: Triantos, Christos, et al.
Publicado: (2018)

Hepatitis B Virus DNA Integration, Chronic Infections and Hepatocellular Carcinoma
por: Bousali, Maria, et al.
Publicado: (2021)

The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis
por: Cholongitas, Evangelos, et al.
Publicado: (2015)

Clinical impact of microbiome in patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2018)

Bacterial infections in patients with liver cirrhosis: clinical characteristics and the role of C-reactive protein
por: Deutsch, Melanie, et al.
Publicado: (2018)

Management of Patients with Inflammatory Diseases during the COVID-19 Pandemic
por: Apostolou, Theofanis, et al.
Publicado: (2020)

Ultrasonographic assessment of diaphragmatic contraction and relaxation properties: correlations of diaphragmatic displacement with oesophageal and transdiaphragmatic pressure
por: Koco, Entela, et al.
Publicado: (2021)

Endotoxin Translocation and Gut Barrier Dysfunction Are Related to Variceal Bleeding in Patients With Liver Cirrhosis
por: Triantos, Christos, et al.
Publicado: (2022)

Primary pyomyositis and disseminated septic pulmonary emboli: a reactivated staphylococcal infection?
por: Savvidou, Savvoula, et al.
Publicado: (2014)

The significance of C-reactive protein to albumin ratio in patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2020)

The significance of platelet microparticles in patients with chronic hepatitis C and their association with antiviral treatment and smoking
por: Kanellopoulou, Theoni, et al.
Publicado: (2016)

Emerging Diagnostic Tools to Decide When to Discontinue Nucleos(t)ide Analogues in Chronic Hepatitis B
por: Papatheodoridi, Margarita, et al.
Publicado: (2020)

Congenital broncho-oesophageal fistula: An unusual cause of persistent pneumonia in a young adult
por: Savvoula, Savvidou, et al.
Publicado: (2013)

The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
por: Varbobitis, Ioannis, et al.
Publicado: (2016)

Aspartate aminotransferase-to-platelet ratio index can predict the outcome in patients with stable decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uereqt351almh2v24ovnsf68fi